Summer Associate 2021 Hunter Louderback

Prior to law school, Hunter Louderback worked in the startup and venture capital industry helping start several companies in the life science and digital therapeutic space. He helped develop and implement a variety of pre-clinical and clinical development plans for several FDA-regulated drugs, devices, and software platforms. Hunter is very interested in the interplay between intellectual property law and healthcare and regulatory law and is excited to utilize his previous experiences in his work this summer.

Hunter graduated with a Master of Science in Biology, Entrepreneurial Biotechnology Track, from Case Western Reserve University and is currently attending law school at Case Western. In 2021, Hunter served as the Team Leader for his school’s team at the National Patent Application Drafting Competition through the United States Patent and Trademark Office and qualified for the national phase of the tournament as one of the top 5 teams in the country. Hunter will also serve as the President of the Student Intellectual Property Law Association for this upcoming school year (2021-2022).

Hunter will be focusing his time working with attorneys who serve our Life Science and Digital Health clients.

Click here to connect with Hunter on LinkedIn and wish him well.

Welcome aboard, Hunter!

Here’s what Hunter had to say about his summer plans:

What are you most excited to learn this summer working for Nixon Gwilt?

“I am thrilled to be working with Nixon Gwilt this summer and am very interested in learning more about the specific legal challenges that many of the emerging businesses and startups face as they develop and scale towards the market. Overall, I’m very excited to learn more about everything in this exciting industry and work with many of the great companies with whom Nixon Gwilt works!”

What do you see as the most exciting innovation in healthcare/life science right now?

“For one, I was really excited to see the development of the mRNA vaccines for COVID-19. I think platform technologies, such as the mRNA vaccines, are a thrilling technology that could see the rapid development of vaccine candidates for a variety of diseases. My thesis research was on a heroin addiction vaccine, which used a very different platform, but I am really partial to vaccine technologies and am excited to see those successes in the industry.”

What social causes are you most passionate about?

“I’ve always been very passionate about fighting homelessness and childhood hunger and have worked with a variety of organizations starting in high school that are really great. I am also really passionate about stemming the effects of the opioid epidemic, especially neonatal abstinence syndrome, having worked in that field for a number of years prior to law school.”